Engrail Therapeutics

Engrail Therapeutics

Acquiring, developing and commercializing transformative medicines.

Launch date
Employees
Market cap
-
Enterprise valuation
€571—856m (Dealroom.co estimates Mar 2024.)
San Diego California (HQ)
Authorizing premium user...